Related Experiment Video
Updated: Mar 20, 2026
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Human Meningitis-Associated Escherichia coli
1Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Abstract:
Escherichia coli is the most common Gram-negative bacillary organism causing meningitis, and E. coli meningitis continues to be an important cause of mortality and morbidity throughout the world. Our incomplete knowledge of its pathogenesis contributes to such mortality and morbidity. Recent reports of E. coli strains producing CTX-M-type or TEM-type extended-spectrum β-lactamases create a challenge. Studies using in vitro and in vivo models of the blood-brain barrier have shown that E. coli meningitis follows a high degree of bacteremia and invasion of the blood-brain barrier. E. coli invasion of the blood-brain barrier, the essential step in the development of E. coli meningitis, requires specific microbial and host factors as well as microbe- and host-specific signaling molecules. Blockade of such microbial and host factors contributing to E. coli invasion of the blood-brain barrier is shown to be efficient in preventing E. coli penetration into the brain. The basis for requiring a high degree of bacteremia for E. coli penetration of the blood-brain barrier, however, remains unclear. Continued investigation on the microbial and host factors contributing to a high degree of bacteremia and E. coli invasion of the blood-brain barrier is likely to identify new targets for prevention and therapy of E. coli meningitis.
Insights
Escherichia coli meningitis remains a global health threat due to incomplete understanding of its pathogenesis. Targeting microbial and host factors involved in bacterial invasion of the blood-brain barrier offers potential therapeutic strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Neuroscience
Background:
- Escherichia coli (E. coli) is a leading cause of Gram-negative bacterial meningitis globally.
- E. coli meningitis contributes significantly to mortality and morbidity worldwide.
- Emergence of antibiotic-resistant E. coli strains, such as those producing extended-spectrum beta-lactamases (ESBLs), complicates treatment.
Purpose of the Study:
- To elucidate the pathogenesis of E. coli meningitis, focusing on bacterial invasion of the blood-brain barrier (BBB).
- To identify microbial and host factors critical for E. coli's BBB penetration.
- To explore potential therapeutic targets for preventing and treating E. coli meningitis.
Main Methods:
- Utilized in vitro and in vivo models of the blood-brain barrier.
- Investigated the role of specific microbial and host factors in E. coli BBB invasion.
- Examined microbe- and host-specific signaling molecules involved in meningitis development.
Main Results:
- E. coli meningitis development is contingent upon high levels of bacteremia and successful invasion of the BBB.
- Specific microbial and host factors, along with signaling molecules, are essential for E. coli's BBB penetration.
- Blocking these identified factors demonstrates efficacy in preventing E. coli entry into the brain.
Conclusions:
- Understanding the factors driving high bacteremia and BBB invasion is crucial for combating E. coli meningitis.
- Targeting microbial and host interactions at the BBB presents a promising avenue for novel preventative and therapeutic interventions.
- Further research into these factors will likely yield new strategies to reduce the impact of E. coli meningitis.
More Related Videos
11:00Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli
Published on: April 20, 2021
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Related Concept Videos
01:18Bacterial Gastroenteritis
01:18Viral Meningitis
01:14Atypical Pneumonia
01:30Reservoir of Infection